MODULON 200 MG
TRIMEBUTINE MALEATE : 200 MG · DIN 00803499 · APTALIS PHARMA CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is MODULON?
MODULON 200 MG contains TRIMEBUTINE MALEATE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 00803499, held by APTALIS PHARMA CANADA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 28-Jan-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00803499 |
|---|---|
| Brand name | MODULON |
| Generic / active ingredient | TRIMEBUTINE MALEATE : 200 MG |
| Manufacturer | APTALIS PHARMA CANADA ULC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A03AA05 TRIMEBUTINE |
| AHFS class | 12:08.08 ; 56:32.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 28-Jan-2019 |
| Original market date | 1991-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A03AA05 TRIMEBUTINE. 4 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-TRIMEBUTINE | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 02245663 |
| APO-TRIMEBUTINE | 200 MG | TABLET | APOTEX INC | MARKETED | DIN 02245664 |
| MINT-TRIMEBUTINE | 100 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02538202 |
| MINT-TRIMEBUTINE | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02538210 |
| MODULON INJ 50MG/5ML | 10 MG / 1 ML | LIQUID | AXCAN PHARMA INC | CANCELLED POST MARKET | DIN 00587850 |
| MODULON TAB 100MG | 100 MG | TABLET | AXCAN PHARMA INC | CANCELLED POST MARKET | DIN 00587869 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.